259 related articles for article (PubMed ID: 23841120)
1. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
Urganci N; Kalyoncu D
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
[TBL] [Abstract][Full Text] [Related]
2. Response to hepatitis A and B vaccination in pediatric patients with celiac disease.
Urganci N; Kalyoncu D
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):408-11. PubMed ID: 23132166
[TBL] [Abstract][Full Text] [Related]
3. Response to hepatitis A and B vaccination in patients with chronic hepatitis C: 8-year follow-up.
Kalyoncu D; Urganci N
Paediatr Int Child Health; 2012 Aug; 32(3):136-9. PubMed ID: 22824660
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease.
Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH
Inflamm Bowel Dis; 2014 Jan; 20(1):69-74. PubMed ID: 24284413
[TBL] [Abstract][Full Text] [Related]
7. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
[TBL] [Abstract][Full Text] [Related]
8. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
11. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
Shapiro AJ; Esther CR; Leigh MW; Dellon EP
Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
14. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
Rosa MN; Hessel G; Alves De Tommaso AM
Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
[TBL] [Abstract][Full Text] [Related]
15. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease.
Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
Inflamm Bowel Dis; 2013 Mar; 19(3):554-8. PubMed ID: 23380936
[TBL] [Abstract][Full Text] [Related]
17. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
[TBL] [Abstract][Full Text] [Related]
18. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
[TBL] [Abstract][Full Text] [Related]
19. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]